NCT00731627View on ClinicalTrials.gov

Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial

PHASE3CompletedINTERVENTIONAL

Enrollment

803

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2013

Study Completion Date

February 28, 2014

Conditions

Subarachnoid Haemorrhage

Interventions

DRUG

placebo

one tablet a day for up to 21 days

DRUG

simvastatin

simvastatin 40mg once a day for a maximum of 21 days

Trial Locations (2)

32224

Mayo Clinic, Jacksonville

32610

Dept of Neurological Surgery, University of Florida, Gainesville

All Listed Sponsors

collaborator

British Heart Foundation

OTHER

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT00731627 - Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial | Biotech Hunter | Biotech Hunter